v3.26.1
Summary of Significant Accounting Policies - Orthobiologics Business (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Nov. 08, 2023
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2026
Jun. 30, 2025
Summary of Significant Accounting Policies          
Proceeds from sale of Orthobiologics Business       $ 425  
Divestiture of Orthobiologics | Discontinued Operations, Disposed of by Sale          
Summary of Significant Accounting Policies          
Proceeds from sale of Orthobiologics Business $ 14,600        
Additional amount that may be earned $ 20,000        
Earn-out payments, as a percent actual revenue 10.00%        
Earn-out period 5 years        
Earn-out payments received       0 $ 0
Recognized a gain   $ 200 $ 6,000    
Indemnity holdback amount $ 1,500        
Retainment Period 24 months        
Indemnity holdback amount resolved and received       $ 400